Your browser doesn't support javascript.
loading
An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
Guo, Yan; He, Wenhui; Mou, Huihui; Zhang, Lizhou; Chang, Jing; Peng, Shoujiao; Ojha, Amrita; Tavora, Rubens; Parcells, Mark S; Luo, Guangxiang; Li, Wenhui; Zhong, Guocai; Choe, Hyeryun; Farzan, Michael; Quinlan, Brian D.
Afiliação
  • Guo Y; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • He W; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • Mou H; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • Zhang L; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • Chang J; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • Peng S; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • Ojha A; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • Tavora R; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • Parcells MS; Department of Animal and Food Sciences, University of Delaware, Newark, Delaware, USA.
  • Luo G; Department of Microbiology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Li W; National Institute of Biological Sciences, Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing, China.
  • Zhong G; Scripps Research SZBL Chemical Biology Institute, Shenzhen Bay Laboratory, Shenzhen, China.
  • Choe H; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Farzan M; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
  • Quinlan BD; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA mfarzan@scripps.edu bquinlan@scripps.edu.
mBio ; 12(3)2021 05 11.
Article em En | MEDLINE | ID: mdl-33975938
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunogenicidade da Vacina / Receptores de Coronavírus / Enzima de Conversão de Angiotensina 2 / Vacinas contra COVID-19 Limite: Animals / Female / Humans Idioma: En Revista: MBio Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunogenicidade da Vacina / Receptores de Coronavírus / Enzima de Conversão de Angiotensina 2 / Vacinas contra COVID-19 Limite: Animals / Female / Humans Idioma: En Revista: MBio Ano de publicação: 2021 Tipo de documento: Article